Allergy Therapeutics PLC - ESG Rating & Company Profile powered by AI
Jump to the bottom of this webpage for potential risks for Allergy Therapeutics PLC based on industry, geography and marketcap. The page includes a Q&A table on Allergy Therapeutics PLC. Other companies in the rating industry group for Allergy Therapeutics PLC are shown.
Allergy Therapeutics PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.3; made up of an environmental score of 5.3, social score of 1.6 and governance score of 6.0.
4.3
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
910 | Vaxcyte Inc | 4.4 | High |
910 | Yield10 Bioscience Inc | 4.4 | High |
951 | Allergy Therapeutics PLC | 4.3 | High |
951 | Cerecor Inc | 4.3 | High |
951 | Athersys Inc | 4.3 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Allergy Therapeutics PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Allergy Therapeutics PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Allergy Therapeutics PLC report the average age of the workforce?
Sign up for free to unlockDoes Allergy Therapeutics PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Allergy Therapeutics PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Allergy Therapeutics PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Allergy Therapeutics PLC offer flexible work?
Sign up for free to unlockDoes Allergy Therapeutics PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Allergy Therapeutics PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Allergy Therapeutics PLC conduct supply chain audits?
Sign up for free to unlockDoes Allergy Therapeutics PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Allergy Therapeutics PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Allergy Therapeutics PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Allergy Therapeutics PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Allergy Therapeutics PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Allergy Therapeutics PLC disclose water use targets?
Sign up for free to unlockDoes Allergy Therapeutics PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Allergy Therapeutics PLC have a product recall in the last two years?
Sign up for free to unlockDoes Allergy Therapeutics PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Allergy Therapeutics PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Allergy Therapeutics PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Allergy Therapeutics PLC disclose parental leave metrics?
Sign up for free to unlockDoes Allergy Therapeutics PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Allergy Therapeutics PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Allergy Therapeutics PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Allergy Therapeutics PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Allergy Therapeutics PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Allergy Therapeutics PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Allergy Therapeutics PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Allergy Therapeutics PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Allergy Therapeutics PLC disclose its waste policy?
Sign up for free to unlockDoes Allergy Therapeutics PLC report according to TCFD requirements?
Sign up for free to unlockDoes Allergy Therapeutics PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Allergy Therapeutics PLC disclose energy use targets?
Sign up for free to unlockDoes Allergy Therapeutics PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Allergy Therapeutics PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Allergy Therapeutics PLC
These potential risks are based on the size, segment and geographies of the company.
Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.